Clinical trial
Beta-CIT-SPECT and Neurophysiology in Depression
NCT00145132 · Ludwig-Maximilians - University of Munich, Other · Completed
Key facts
| NCT number | NCT00145132 |
|---|---|
| Title | Beta-CIT-SPECT and Neurophysiology in Depression |
| Official title | Serotonin and Dopamine Transporter (SERT, DAT) Availabilities as Assessed by b-CIT and SPECT, and Neurophysiological Measures of Central Serotonergic Activity in Patients With Depression Under Treatment With Escitalopram |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Collaborators | H. Lundbeck A/S Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Procedure |
| Interventions | β-CIT-SPECT, Neurophysiology |
| Enrollment | 30 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 5, 2005 |
| Last update posted | Jun 2, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: